Compile Data Set for Download or QSAR
Report error Found 8 Enz. Inhib. hit(s) with all data for entry = 50008044
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50059715(4-Furan-3-yl-7-[6-(3-hydroxy-6,8-dioxa-bicyclo[3.2...)
Affinity DataIC50: 20nMAssay Description:Compound was evaluated for in vitro inhibition of recombinant human 5-lipoxygenase (5-LO)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50070314(7-[3-Fluoro-5-(3-hydroxy-6,8-dioxa-bicyclo[3.2.1]o...)
Affinity DataIC50: 27nMAssay Description:Compound was evaluated for in vitro inhibition of recombinant human 5-lipoxygenase (5-LO)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50070310(4-Furan-3-yl-7-[6-(3-hydroxy-6,8-dioxa-bicyclo[3.2...)
Affinity DataIC50: 36nMAssay Description:Compound was evaluated for in vitro inhibition of recombinant human 5-lipoxygenase (5-LO)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50070312(1-Benzyl-4-furan-3-yl-7-[6-(3-hydroxy-6,8-dioxa-bi...)
Affinity DataIC50: 102nMAssay Description:Compound was evaluated for in vitro inhibition of recombinant human 5-lipoxygenase (5-LO)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50070313(7-[3-Fluoro-5-(3-hydroxy-6,8-dioxa-bicyclo[3.2.1]o...)
Affinity DataIC50: 124nMAssay Description:Compound was evaluated for in vitro inhibition of recombinant human 5-lipoxygenase (5-LO)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50070308(3-[6-(4-Furan-3-yl-isoquinolin-7-yloxymethyl)-pyri...)
Affinity DataIC50: 1.46E+3nMAssay Description:Compound was evaluated for in vitro inhibition of recombinant human 5-lipoxygenase (5-LO)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50070311(1-Furan-3-yl-6-[6-(3-hydroxy-6,8-dioxa-bicyclo[3.2...)
Affinity DataIC50: 1.96E+3nMAssay Description:Compound was evaluated for in vitro inhibition of recombinant human 5-lipoxygenase (5-LO)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPolyunsaturated fatty acid 5-lipoxygenase(Human)
Merck Frosst Centre For Therapeutic Research

Curated by ChEMBL
LigandPNGBDBM50070309(4-Furan-3-yl-7-[3-(3-hydroxy-6,8-dioxa-bicyclo[3.2...)
Affinity DataIC50: 3.00E+3nMAssay Description:Compound was evaluated for in vitro inhibition of recombinant human 5-lipoxygenase (5-LO)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed